Prof. Dr. Suttipong Wacharasindhu, Director of King Chulalongkorn Memorial Hospital and Dean of the Faculty of Medicine, Chulalongkorn University together with Assoc. Prof. Virote Sriuranpong, PhD., Head of Chulalongkorn Comprehensive Cancer Center, Prof. Dr. Nattiya Hirankarn, Head of Chulalongkorn Cancer Immunotherapy Excellence Center and Dr. Trairak Pisitkun, Head of Systems Biology Center, Chulalongkorn University, presided over a press conference to announce new innovations in cancer treatment, at Bhumisiri Mangalanuson Building, King Chulalongkorn Memorial Hospital, on 24 October 2018.
The Chula team announced that they had made progress in the research to develop immunotherapy treatment for cancer. After they began cancer immunotherapy research last year, researchers have achieved their first-phase objective. However, there is a long way to go until a biologic drug can be developed to treat cancer. The project is now only in the initial phase and the team would like to seek continuous partnership and contributions for the research path ahead.
To support this research and development, please make a deposit to the bank account of the Faculty of Medicine,Chulalongkorn University, Siam Commercial Bank, Saving Account No. 408-004443-4 and Current Account No. 045-304669-7.
Source: The Thai Red Cross Society